Guided Therapeutics (GTHP) Net Income towards Common Stockholders (2010 - 2025)
Guided Therapeutics recorded quarterly Net Income towards Common Stockholders of -$1.2 million in Q4 2025, down 52.36% quarter-over-quarter from -$785000.0 in Q3 2025, and down 70.86% year-over-year from -$4.1 million in Q4 2024.
Guided Therapeutics' Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$1.2 million for Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders fell 70.86% year-over-year to -$1.2 million; the TTM figure through Dec 2025 stood at -$3.3 million (down 27.36% YoY), while the FY2025 annual figure was -$3.3 million, down 27.36% from the prior year.
- Net Income towards Common Stockholders came in at -$1.2 million for Q4 2025 at Guided Therapeutics, down from -$785000.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$51000.0 in Q3 2021 to a low of -$1.9 million in Q4 2022.
- A 5-year average of -$845700.0 and a median of -$771500.0 in 2024 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders surged 82.87% in 2021 and slumped 1966.67% in 2022, its largest moves.
- Guided Therapeutics' Net Income towards Common Stockholders stood at -$509000.0 in 2021, then sank by 264.83% to -$1.9 million in 2022, then jumped by 74.74% to -$469000.0 in 2023, then sank by 49.25% to -$700000.0 in 2024, then tumbled by 70.86% to -$1.2 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.2 million, -$785000.0, and -$856000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.20 Mn |
| Sep 30, 2025 | -785,000.00 |
| Jun 30, 2025 | -856,000.00 |
| Mar 31, 2025 | -463,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | -692,000.00 |
| Jun 30, 2024 | -758,000.00 |
| Mar 31, 2024 | -441,000.00 |
| Dec 31, 2023 | -469,000.00 |
| Sep 30, 2023 | -717,000.00 |
| Jun 30, 2023 | -1.60 Mn |
| Mar 31, 2023 | -969,000.00 |
| Dec 31, 2022 | -1.86 Mn |
| Sep 30, 2022 | -1.05 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | -509,000.00 |
| Sep 30, 2021 | -51,000.00 |
| Jun 30, 2021 | -1.16 Mn |
| Mar 31, 2021 | -572,000.00 |
| Dec 31, 2020 | 2.12 Mn |
| Sep 30, 2020 | 1.53 Mn |
| Jun 30, 2020 | -6.77 Mn |
| Mar 31, 2020 | 2.72 Mn |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | -126,000.00 |
| Jun 30, 2019 | -2.65 Mn |
| Mar 31, 2019 | -224,000.00 |
| Dec 31, 2018 | -2.75 Mn |
| Sep 30, 2018 | -757,000.00 |
| Jun 30, 2018 | 3.38 Mn |
| Mar 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | -7.21 Mn |
| Sep 30, 2017 | -2.42 Mn |
| Jun 30, 2017 | -1.14 Mn |
| Mar 31, 2017 | -206,000.00 |
| Dec 31, 2016 | -2.09 Mn |
| Sep 30, 2016 | -390,000.00 |
| Jun 30, 2016 | -2.17 Mn |
| Mar 31, 2016 | -340,000.00 |
| Dec 31, 2015 | -2.49 Mn |
| Sep 30, 2015 | -2.74 Mn |
| Jun 30, 2015 | -3.00 Mn |
| Mar 31, 2015 | -1.28 Mn |
| Dec 31, 2014 | -3.22 Mn |
| Sep 30, 2014 | -3.01 Mn |
| Jun 30, 2014 | -2.19 Mn |
| Mar 31, 2014 | -1.61 Mn |
| Dec 31, 2013 | -4.22 Mn |
| Sep 30, 2013 | -1.44 Mn |
| Jun 30, 2013 | -2.92 Mn |
| Mar 31, 2013 | -1.82 Mn |
| Dec 31, 2012 | -1.19 Mn |
| Sep 30, 2012 | -986,000.00 |
| Jun 30, 2012 | -1.17 Mn |
| Mar 31, 2012 | 1.01 Mn |
| Dec 31, 2011 | 2.76 Mn |
| Sep 30, 2011 | 2.66 Mn |
| Jun 30, 2011 | -496,000.00 |
| Mar 31, 2011 | 726,000.00 |
| Jun 30, 2010 | -559,000.00 |